The Hepatitis E Virus (HEV) infection is one of the main causes of acute viral hepatitis. This affection is generally asymptomatic and benign. Its incidence is elevated in sub Saharan Africa. In Human Immunodeficiency Virus (HIV) infected patients, the HEV can cause chronic hepatitis with risks of cirrhosis and cancer. Assessing the prevalence and risk factors of an HEV infection in people living with HIV can help to prevent the transmission and the onset of their complications. The aim of this study was to evaluate the seroprevalence of HEV markers and associated factors among HIV infected patients in Yaoundé (Cameroon). Ninety HIV infected patients were included in this study, with 29 men (32.2%) and 61 women (67.8%). The mean age was 46 ± 11.4 years old (21 -74). The prevalence of HEV serological markers was 6.7% and 12.2% for immunoglobulins (IgG) and IgM respectively. Both IgG and IgM were positive for 2 patients (2.2%), while 15 patients (16.7%) had at least one immunoglobin positive. The consumption of well water and porcine foods was found to be associated with the presence of IgM HEV antibodies. There was no association between CD4 count, viral load and the presence of HEV serological markers.
Background: Human Immunodeficiency Virus (HIV) infection is a major public health problem in Africa, which alone recorded 71% of HIV / AIDS-related deaths in 2018. There is a link between the infection to HIV and the occurrence of certain cancers, in particular digestive cancers. Very little data in Africa, especially Cameroon, exists on the association between HIV and digestive cancers. Our goal was to determine the prevalence of HIV in patients with cancer of the digestive tract as well as the factors related to the prognosis of these patients in Cameroon. Methods: We conducted a cross-sectional and analytical study over a 10-year period from January 2010 to December 2019. It was carried out in the general hospitals of the cities of Douala and Yaoundé. We included records of patients with histologically confirmed gastrointestinal cancer. We excluded records of patients with lymphoma or Kaposi’s sarcoma. The data collected were socio-demographic, clinical and paraclinical data. Chi-square test was used to determine statistically significant associations for p <0.05. Results: We collected 294 files, among which 71 had positive HIV serology, either a prevalence of 24.15%. The average age of the patients was 53,7±13,6 years old. The sex ratio was 1.08. The main locations were the colon with 28.7% (N = 20) and the anus with 25.4% (N = 18). At the time of HIV diagnosis, the mean CD4 count at the time of HIV diagnosis was 413,2±189,3/mm3 and the mean viral load was 5129±2786,8copies/mm3. When diagnosed with cancer, the average CD4 count was 287,84±101,7/mm3 and the average viral load was 25385,5±19784,3/mm3. The anal location (p = 0.003), the necrotic appearance (p = 0.001), the poorly differentiated character (p = 0.02) of the tumors and the death of the patients (p = 0.000) were statistically linked to positive HIV serology. Factors associated with the prognosis of HIV positive patients were CD4 count <200 / mm3 (p = 0.002) and the existence of metastases (p = 0.04) Conclusion: The prevalence of HIV in patients with cancer of the digestive tract is 24.15%. The anal location, the necrotic appearance and the undifferentiated nature of the tumors are related to positive HIV serology. Prognostic factors are a CD4 count <200 / mm3 and the existence of metastases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.